about
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activityFasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition.Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cellsStructural alterations of human serum albumin caused by glycative and oxidative stressors revealed by circular dichroism analysisCardioprotection and anticholinesterases in patients with Alzheimer's disease: time for reappraisal.A calcified lipoma of the foot in a 100-year-old Italian woman.Vitamin C, Aging and Alzheimer's Disease.Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.Physician assisted suicide and clinical vulnerability: a slippery slope.Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer's Disease.For debate: The August sun and the December snow.Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin.Reliability study in five languages of the translation of the pain behavioural scale Doloplus.Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro.A Dedicated Nutritional Care Program (NUTRICARE) to reduce malnutrition in institutionalised dysphagic older people: A quasi-experimental study.Artificial neural networks identify the predictive values of risk factors on the conversion of amnestic mild cognitive impairment.The epidemiology of domestic injurious falls in a community dwelling elderly population: an outgrowing economic burden.Pentosidine determination in CSF: a potential biomarker of Alzheimer's disease?Doloplus-2 pain assessment: an effective tool in patients over 85 years with advanced dementia and persistent pain.Preoperative risk factors for postoperative delirium (POD) after urological surgery in the elderly.Pentosidine effects on human osteoblasts in vitro.Survival rate in patients affected by dementia followed by memory clinics (UVA) in Italy.Advanced glycation end products and bone loss during aging.Possible predictors of age at illness onset and illness duration in a cohort study comparing younger adults and older major affective patients.Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.Reliability Study in Five Languages of the Translation of the Pain Observational Scale Algoplus.Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status.4-Hydroxyhexenal and 4-hydroxynonenal are mediators of the anti-cachectic effect of n-3 and n-6 polyunsaturated fatty acids on human lung cancer cells.Validation of the Photography Method for Nutritional Intake Assessment in Hospitalized Elderly Subjects.Delirium, Frailty, and Fast-Track Surgery in Oncogeriatrics: Is There a Link?Personality traits and behavioral disturbances in dementia: A new risk factor?Valproate-induced encephalopathy in a comorbid elderly woman.Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wardsEvaluation of prognostic indices in elderly hospitalized patientsEffects of Two Types of 9-Month Adapted Physical Activity Program on Muscle Mass, Muscle Strength, and Balance in Moderate Sarcopenic Older WomenEffects of valsartan therapy on protein glycoxidationCorrelation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysisTelephone calls provide effective support for most caregivers of patients with dementia but not for allMetalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology?Algoplus® Scale in Older Patients with Dementia: A Reliable Real-World Pain Assessment Tool
P50
Q34634272-C40FE069-C366-4343-9CA6-0BFFEB9BFC8CQ35828447-0D5B6E76-12BC-42D7-859A-45ED9D3D537EQ36651351-A483B199-3EF5-4C01-91EF-B51ABDBC42E9Q37007052-1D3E7254-C8A9-4FB6-8DC8-C4EED8B747C9Q37687520-6F957576-C470-47D8-94E0-7B90B3C86EA1Q38556017-1CCC1AC3-AC85-4E13-A159-8BB5556214E4Q38666196-1248529A-64C8-4DCE-9DA1-453CD931E144Q38703414-D2C374E2-E39C-4805-BBB7-40023A978290Q38795331-E05880D2-0699-44C3-AE11-265B4A54DEFFQ39005365-8055A12C-24AD-47B9-B663-C3BDF4DDD427Q39110608-D95F9F64-CDDE-437E-B169-6DF026150EACQ39195646-6C480270-9661-4263-B555-DC8DD7C4F1A5Q39947746-36B6245D-3075-4B54-A3CD-4F84B85CE57AQ40025987-AEAD11A6-F963-4FCB-9E32-09742DDD80F5Q40320412-F92FDFA1-F519-4E7B-BB17-50814CBCF2D8Q43161327-6E476199-61A8-4AB1-ACB9-0684164952B1Q43646987-74959617-6BDC-434F-9136-0919EE149B85Q43654861-182AACBE-6928-4182-9FA8-F998E19281C7Q43765411-351A56F4-2F66-4A05-9E2F-079ED413558DQ43768302-EB6D5471-39C7-4980-A49B-C7D994442BC6Q44843167-158AF890-01D7-461A-A4F2-7AFD0F06EABFQ45720515-E2EB37D0-0021-4EEA-91F7-5676293212CDQ46613220-DFEA131A-4D13-4829-A948-31DEA60AC26CQ47620491-87F89689-C288-4553-B41F-A67DD5991DA7Q48425057-AA575EC7-0C30-4247-9131-E84559219A28Q48676883-9EDAA865-7062-452D-843F-9C56C5A92420Q49372280-657F1C1D-B01A-4D72-8662-9251EBF5DF38Q51129765-D037561B-D58E-4FF9-BE73-401B8858988DQ51820632-6FECA53C-D014-4931-AE1C-7987C8603418Q52668307-7AB33089-6895-4AB9-B007-BE6ACD951596Q53290467-BB5883AE-DACB-4D2A-8906-D2B8FD9DF98FQ54285268-F01E4D5C-0221-4038-9B22-80E9AFBC09EBQ56380062-0FD4FB1B-866A-46D8-960F-19104E4A737CQ58197541-173079D5-2F9E-45D1-997D-1D67A489A993Q58699300-FC9BABAA-5C86-4BED-8194-3A8074BB1FE5Q79400500-B68B6776-634F-47A9-BE71-0EC2F66190E4Q79427836-5349AB28-CB9D-40A7-9A7F-AD9EADAE6ECCQ83186366-82ADB69A-BBEE-48B5-8432-BD70E175C105Q85207597-DD18CF61-FE5E-47E8-8E82-F299FF4B0A44Q88935033-B89F363D-C15C-43A6-ABC1-44E4B1A3A436
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fiammetta Monacelli
@ast
Fiammetta Monacelli
@en
Fiammetta Monacelli
@es
Fiammetta Monacelli
@nl
type
label
Fiammetta Monacelli
@ast
Fiammetta Monacelli
@en
Fiammetta Monacelli
@es
Fiammetta Monacelli
@nl
prefLabel
Fiammetta Monacelli
@ast
Fiammetta Monacelli
@en
Fiammetta Monacelli
@es
Fiammetta Monacelli
@nl
P106
P1153
8692938800
P31
P496
0000-0003-4303-7252